story of the week
Tumor Lysis Syndrome and Infectious Complications During Treatment With Venetoclax Plus Azacitidine or Decitabine in Patients With AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia
Leuk. Res 2022 Apr 25;117(xx)106844, S Arora, C Zainaldin, S Bathini, U Gupta, S Worth, K Bachiashvili, R Bhatia, K Godby, O Jamy, S Rangaraju, B Diamond, JD Oliver, D Salzman, A Di Stasi, P VachhaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.